Deborah H. Telman - 25 Oct 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
25 Oct 2024
Net transactions value
-$21,538
Form type
4
Filing time
28 Oct 2024, 15:09:29 UTC
Previous filing
11 Sep 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +514 +2.5% 21,221 25 Oct 2024 Direct F1
transaction GILD Common Stock Tax liability $21,538 -242 -1.1% $89.00 20,979 25 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -514 -1.7% 29,033 25 Oct 2024 Common Stock 514 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.